Medical research into new cancer therapies is at the heart of a new collaboration between Australian and United States’ researchers. The strong ties that exist between researchers in the two countries were highlighted recently when US Vice President, Joe Biden, visited the Victorian Comprehensive Cancer Centre (VCCC) in July.
Both countries share a common goal to solve the complex nature of cancer, through strong partnerships with international research centres that are on the cutting edge of this work.
At the heart of this research in Australia will be VCCC’s new $1 billion purpose-built facility in Melbourne that will host up to 1200 cancer researchers. This facility is the largest of its type in the southern hemisphere and one of the top 10 cancer centres in the world.
The research centre will bring together specialists and researchers from the Peter McCallum Cancer Centre, The Doherty Institute and the University of Melbourne. The Peter MacCallum Cancer Centre already has strong ties with the US and this new centre will help them build on their shared knowledge and experiences.
Much of the research conducted at the new centre will be in the exciting field of immunotherapy – a new treatment modality that is revolutionising cancer care and personalised treatment. The focus will be on immune-based therapy research that can then progress to clinical trials to accelerate better treatment and outcomes.